Gynesonics, Inc. is a company focused on advancing technology to improve women's lives. They specialize in transvaginal fibroid ablation, offering the world’s first and only intrauterine fibroid ablation system, which combines ultrasound guidance with targeted radiofrequency energy for a transcervical, incisionless procedure. Their flagship product, the Sonata System, is designed for the treatment of symptomatic uterine fibroids. Gynesonics emphasizes the safety and effectiveness of their technology, thereby enhancing healthcare solutions for women.
October 31
Sells Gynesonics medical technology to healthcare providers in assigned territory.